Remifentanil vs. Lidocaine on Response to Tracheal Tube during Emergence of General Anesthesia

Message:
Abstract:
Introduction
Response to tracheal tube during emergence of general anesthesia is a main concern. We aimed to compare the effect of Remifentanil and Lidocaine on response to tracheal tube during emergence of general anesthesia.
Materials And Methods
In this randomized clinical trial, we enrolled 80 consecutive patients with American Society of Anesthesiology (ASA) physical status I–II, who underwent general anesthesia for general surgery in Amir-Al-Momenin Hospital on Zabol University of medical sciences from May 2011 to September 2011. Patients received either i.v. lidocaine 1.5 mg /kg (Group L) or 0.5mic/kg/min of Remifentanil (Group R) for emergence from anesthesia.
Results
The frequency of cough during emergence from general anesthesia was significantly higher in Group L than in Group R (70.7% vs. 40.3%, P=0.014). Also the grade of cough during the emergence was significantly higher in Group L than in Group R (P=0.013).The difference between two groups regarding sedation level, visual analogue scale (VAS), and pethidine consumption were not significant (P=0.08).
Conclusion
we specified Remifentanil reduces cough during the emergence from general anesthesia more effective than Lidocaine in patients undergoing general surgery. In addition, Remifentanil and i.v. lidocaine revealed comparable impact regarding VAS scoring, sedation level and pethidine consumption.
Language:
English
Published:
Journal of Cardio -Thoracic Medicine, Volume:2 Issue: 3, Summer 2014
Pages:
198 to 202
magiran.com/p1296005  
دانلود و مطالعه متن این مقاله با یکی از روشهای زیر امکان پذیر است:
اشتراک شخصی
با عضویت و پرداخت آنلاین حق اشتراک یک‌ساله به مبلغ 1,390,000ريال می‌توانید 70 عنوان مطلب دانلود کنید!
اشتراک سازمانی
به کتابخانه دانشگاه یا محل کار خود پیشنهاد کنید تا اشتراک سازمانی این پایگاه را برای دسترسی نامحدود همه کاربران به متن مطالب تهیه نمایند!
توجه!
  • حق عضویت دریافتی صرف حمایت از نشریات عضو و نگهداری، تکمیل و توسعه مگیران می‌شود.
  • پرداخت حق اشتراک و دانلود مقالات اجازه بازنشر آن در سایر رسانه‌های چاپی و دیجیتال را به کاربر نمی‌دهد.
In order to view content subscription is required

Personal subscription
Subscribe magiran.com for 70 € euros via PayPal and download 70 articles during a year.
Organization subscription
Please contact us to subscribe your university or library for unlimited access!